Collplant Holdings Ltd

From Verify.Wiki
Jump to: navigation, search
Collplant.jpg
http://www.collplant.com/
Collplant Holdings Ltd
Type Public
Industry Medical Device, Health Care, Biotechnology
Founded 2004
Slogan Revolutionizing Tissue Repair
Headquarters Ness Ziona, HaMerkaz, Israel
Key people Oded Shoseyov (Founder), Yehiel Tal (CEO), Eran Rotem (CFO), Dr. Ilana Belzar (COO) [1]
Investors Docor International Management, Meitav Underwriting, Modgal Industries, Pontifax [2]
Number of employees 37 [3]

CollPlant Holdings Ltd. produces and distributes pharmaceutical products. The Company offers wound care, orthopedics, and tissue repair medicines. CollPlant Holdings conducts its business in the United States. [4]
It is a medical device company focused on advancing regenerative medicine by utilizing its proprietary processing technologies for human collagen and other recombinant proteins. The company is developing a substantial range of biomaterials-based products applicable in multiple medical markets, including orthopaedics, wound management, cardiology and general surgery.
Collplant Holdings recently filed for U.S. IPO on Oct 21, 2016, applied to list ADSS on Nasdaq, under symbol "CLGN"; Ladenburg Thalmann and Roth Capital are underwriter

History

  • 2006 - Collplant raises $1.5M via Pontifax[5]
  • 2007 - Collplant raises $2M via Pontifax, Meitav Underwriting and Modgal Industries[6]
  • 2007 - Collplant raises $4.5M via Pontifax and Docor International Management[7]
  • 2008 - Collplant raises $8.3M via Pontifax and Docor International Management[8]
  • 2010 - Collplant raises $2m via Pontifax Fund, Meitav Underwriting, Modgal, and private investors
  • Feb 2016 - CollPlant receives CE Mark for Vergenix™FG Wound Filler
  • June 2016 - CollPlant Signs distribution agreement in Italy for Vergenix®FG Wound Care Product
  • Oct 2016 - Collplant files for U.S. IPO

Controversies

Top 5 Recent Tweets

DateAuthorComment
November 29, 2018Stock_News_King$CLGN - Form 6-K CollPlant Holdings Ltd. For: Nov 29
  1. STOCKS #NEWS #NASDAQ #INVESTING


Top 5 Recent News Headlines

  • Collplant Holdings files for U.S. IPO - Collplant Holdings files for U.S. IPO; applied to list ADSS on Nasdaq, under symbol "CLGN"; Ladenburg Thalmann and Roth Capital are underwriters. [9]
  • CollPlant announces Commencement of Commercial Treatments of Vergenix®FG Wound Filler in Europe - The company announced the commencement of commercial treatments of Vergenix®FG (Flowable Gel) wound filler in patients in Italy. [10]
  • CollPlant Reaches Commercial Milestone: Company Signs distribution agreement in Italy for Vergenix®FG Wound Care Product - This is an exclusive, two year agreement, with an option to extend the period. CollPlant expects the first order to be received within the next few days, with delivery of products scheduled for June 2016. [11]
  • CollPlant receives CE Mark for Vergenix™FG Wound Filler - This marks the achievement of a significant milestone and paves the way for sales to begin in Europe in coming months. [12]
  • CollPlant Reports Positive Final Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy - Clinical Success Demonstrated, with Improvement in Pain and Functionality at Three and Six-month Follow-ups. [13]


References

  1. http://www.collplant.com/about/#management-team
  2. https://www.crunchbase.com/organization/collplant#/entity
  3. http://www.nasdaq.com/markets/ipos/company/collplant-holdings-ltd-958513-81929
  4. http://www.bloomberg.com/quote/PTGN/L:IT
  5. https://www.crunchbase.com/funding-round/5aa7b03fb6c6c9616c1ed44426c4e2bb
  6. https://www.crunchbase.com/funding-round/63230326cd63fa0b8a8acc54fc0a6bd6
  7. https://www.crunchbase.com/funding-round/c1f0abc1aa1efedac88863427ab0c742
  8. https://www.crunchbase.com/funding-round/4899826098b8ed66fb84cdb569c9ee5d
  9. http://in.reuters.com/article/idINFWN1CR0HI
  10. http://www.collplant.com/news/collplant-announces-commencement-of-commercial-treatments-of-vergenixfg-wound-filler-in-europe/
  11. http://www.collplant.com/news/collplant-reaches-commercial-milestone-company-signs-distribution-agreement-in-italy-for-vergenixfg-wound-care-product/
  12. http://www.collplant.com/news/collplant-receives-ce-mark-for-vergenix-fg-wound-filler/
  13. http://www.collplant.com/news/collplant-reports-positive-final-trial-results-for-vergenixstr-indicated-for-the-treatment-of-tendinopathy/

Verification history